Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Inventory (2016 - 2025)

Chemours (CC) has 12 years of Inventory data on record, last reported at $1.6 billion in Q4 2025.

  • For Q4 2025, Inventory rose 7.25% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, up 7.25%, while the annual FY2025 figure was $1.6 billion, 7.25% up from the prior year.
  • Inventory reached $1.6 billion in Q4 2025 per CC's latest filing, down from $1.9 billion in the prior quarter.
  • Across five years, Inventory topped out at $1.9 billion in Q2 2025 and bottomed at $988.0 million in Q1 2021.
  • Average Inventory over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2022.
  • Peak YoY movement for Inventory: decreased 28.2% in 2021, then surged 62.8% in 2022.
  • A 5-year view of Inventory shows it stood at $1.4 billion in 2021, then rose by 2.41% to $1.4 billion in 2022, then decreased by 3.92% to $1.3 billion in 2023, then rose by 8.45% to $1.5 billion in 2024, then grew by 7.25% to $1.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $1.6 billion in Q4 2025, $1.9 billion in Q3 2025, and $1.9 billion in Q2 2025.